Mutual of America Capital Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-9,604
Closed -$212K 1472
2023
Q1
$212K Buy
+9,604
New +$225K ﹤0.01% 1383
2022
Q4
Sell
-9,217
Closed -$124K 1480
2022
Q3
$124K Buy
9,217
+1,440
+19% +$24.3K ﹤0.01% 1477
2022
Q2
$154K Buy
7,777
+1,109
+17% +$29.5K ﹤0.01% 1404
2022
Q1
$211K Buy
6,668
+344
+5% +$9.64K ﹤0.01% 1334
2021
Q4
$141K Buy
6,324
+146
+2% +$3.81K ﹤0.01% 1445
2021
Q3
$171K Sell
6,178
-406
-6% -$12.4K ﹤0.01% 1383
2021
Q2
$256K Buy
6,584
+631
+11% +$22.6K ﹤0.01% 1322
2021
Q1
$171K Buy
5,953
+400
+7% +$13.7K ﹤0.01% 1410
2020
Q4
$147K Buy
5,553
+217
+4% +$4.43K ﹤0.01% 1379
2020
Q3
$81K Buy
5,336
+3,166
+146% +$66.4K ﹤0.01% 1438
2020
Q2
$44K Sell
2,170
-39,187
-95% -$702K ﹤0.01% 1366
2020
Q1
$428K Buy
41,357
+1,379
+3% +$38.6K 0.01% 1103
2019
Q4
$1.51M Buy
39,978
+768
+2% +$34.5K 0.02% 1013
2019
Q3
$1.83M Buy
39,210
+35
+0.1% +$1.63K 0.03% 896
2019
Q2
$2.05M Buy
+39,175
New +$2.3M 0.03% 863

Other funds holding CLB

Mutual of America Capital Management's CLB Position: Q2 2023 in Review

Mutual of America Capital Management sold out of Core Laboratories (CLB) in Q2 2023, closing a stake of 9,604 shares — an estimated $212K sold.

Mutual of America Capital Management first reported a position in CLB in Q2 2019 and held it in 15 quarters. The position peaked at $2.05M in Q2 2019. 164 funds tracked by Wall St. Rank hold CLB as of Q2 2023.

  • Mutual of America Capital Management reported no remaining Core Laboratories position as of Q2 2023 after selling out during the quarter.
  • Mutual of America Capital Management sold 9,604 Core Laboratories shares in Q2 2023, an estimated $212K.
  • Mutual of America Capital Management first reported a position in Core Laboratories in Q2 2019 and held it in 15 quarters.
  • Mutual of America Capital Management's Core Laboratories position peaked at $2.05M in Q2 2019.
  • 164 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2023.

Based on Mutual of America Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.